In animal studies, its shown to increase blood flow to a given area through angiogenesis, or the formation of new capillaries
Here at Greenwell Lifesciences, we have a state-of-the-art manufacturing plant having Well-equipped and modern machinery ISO-WHO-GMP-Certified manufacturing plant Spacious and hygienic premises Highly skilled professional with years of hands-on experience in the pharma industry PAN India delivery without fail
Tracing experiments with Dil-labeled HBs and human ALB (hALB) confirmed that the HBs successfully homed to the injured liver and differentiated into mature hepatocytes
Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio
